About MammaPrint MammaPrint is a DNA microarray – based in vitro diagnostic laboratory service, the 70, the activity of genes measures the provision of information on the likelihood of recurrence. The MammaPrint test measures the level of expression of these genes in a sample of a woman ‘s surgically removed breast cancer tumor and then a specific formula or algorithm is score, whether the patient is at low risk or high risk to produce intended for spread of the cancer to a remote location . The result can be a doctor in planning appropriate follow-up for a patient when use to help with other clinical and pathological information http://levitra10mg.biz/what-are-the-common-levitra-side-effects .
Dr. 70, the Director, Molecular Oncology and Advanced Diagnostics Laboratory of William Beaumont Hospital in Royal Oaks, Michigan says: I prefer MammaPrint for for both ER-positive and ER negative breast cancers, since there is no standard provision the ER status the ER status also MammaPrint encompasses many measures the and, as the clinical usefulness complex, the clinical utility of tests with smaller numbers of genes dubious in my opinion. .
The partnership is national knowledge a range of key issues of UK health care including improved inclusion of the patient, better understanding the extension patients have reported outcomes treatment outcomes and evidence of innovation in the care and knowledge transfer from research to practical .